Navigation Links
Hoya Announces Third Quarter Financial Results
Date:2/9/2010

TOKYO, February 9 /PRNewswire-FirstCall/ -- Hoya Corporation today announced financial results for the third quarter ended December 31, 2009. Net sales were 106.8 billion yen for the quarter, a 5.2% decrease from 112.7 billion yen in the same period last year. Operating income was 18.9 billion yen, a 13.8% increase from 16.6 billion yen in the same period last year, mainly due to increase in orders and productivity. Compared to the second quarter ended September 30, 2009, sustained recovery in orders since April resulted in an increase of both net sales and operating income.

Net income for the third quarter was down 6.5% to 11.7 billion yen compared to the same period last year. Earnings per share for the quarter were 27.24 yen compared with 29.13 yen in the same period last year.

"In this anemic economy, the good news is that there is an increase in orders and the demand for larger memory capacity in glass memory disk business," said Hiroshi Suzuki, chief executive officer of HOYA. "The development of technology for 3D television also has a good impact on our LCD photo mask business."

For the first nine months ended December 31, 2009, net sales were 308.6 billion yen, down 16.9% compared to 371.2 billion yen in the same period previous year, operating income was 46.9 billion yen, down 20.6% compared to 59.1 billion yen in the same period previous year, and net income was '/>"/>

SOURCE Hoya Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015  Xcelience, a ... that it has made a structured cash investment ... company specializing in milling, micronization and powder size ... help grow Powdersize,s business while simultaneously adding a ... Xcelience,s portfolio of capabilities. "As ...
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, asthma ... of Yujiro S. Hata to its board ... in business and corporate development is a tremendous asset ... president and chief executive officer of Xencor. "Xencor faces ...
(Date:7/30/2015)... 2015  ResMed (NYSE: RMD ) ... agreement to acquire Curative Medical, a privately-held ... breathing medical devices and accessories. ... leadership in sleep and respiratory medicine, will ... suffering from sleep-disordered breathing and ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... and Company,(NYSE: LLY ) announced today that ... Cymbalta(R) (duloxetine HCl) for the maintenance,treatment of major ... re-emergence of depressive symptoms after a successful,treatment of ... M.D., Cymbalta associate medical director for Eli Lilly ...
... Measles Deaths, Joint News Release: American Red Cross/UN ... 29, Measles deaths in Africa fell by 91 percent,between ... reaching the,United Nations 2010 goal to cut measles deaths ... in Africa helped generate a strong,decline in global measles ...
Cached Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder 4Measles Deaths in Africa Plunge by 91% 2Measles Deaths in Africa Plunge by 91% 3Measles Deaths in Africa Plunge by 91% 4
(Date:7/31/2015)... ... 31, 2015 , ... That’s right, the STASH awards have ... The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in High ... that have stood the test of time. These include lighting products, organic and ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source for authentic ... at Grant Park. The festival will end on Sunday, August 2nd. ... the annual Lollapalooza. This unique and unbelievably popular festival attracts the best in ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Sculpted Contours ... the CoolSmooth PRO this week. Zeltiq Aesthetics released this new applicator in the ... January 2014 for treating the outer thighs. The original applicator required a 2 ...
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of the Smartest Doc ... Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an ... preparing for the exam easy and painless. MDLinx offers thousands of board-exam style ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Brown’s live lecture on pharmaceutical negligence is now available online at ( ... received with a 94% approval rating from the nationwide audience. The ...
Breaking Medicine News(10 mins):Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2
... Warwick Medical School published today in the European ... disrupted sleep patterns can have long-term, serious health implications. ... of sleep to strokes, heart attacks and cardiovascular disorders ... from the University of Warwick Medical School, explained: ...
... issue of the Journal of the American College ... to navigate the unique and increasingly complex U.S. regulatory ... From Concept to Adoption," identifies and addresses the five ... clinical evidence needs for each phase. This article ...
... The use of antipsychotic drugs to treat schizophrenia is associated ... brain tissue, a new study finds. It included 211 ... brain scans over 7.2 years, for a total of 674 ... four factors affected changes in brain volume over time: illness ...
... Day? Here,s some dating advice straight from the laboratory: It turns ... study published in Psychological Science , a journal of the ... to a man when she is uncertain about how much he ... psychological research has found that person A usually likes person B ...
... 7 (HealthDay News) -- The number of Americans having ... statistics released Monday suggest. Last year, there were ... up five percent from 2009, the American Society of ... surgical procedures and 11.6 cosmetic minimally-invasive procedures. The top ...
... Exposure to low-dose radiation from cardiac imaging and other ... increased risk of cancer, found a new study published ... ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100463.pdf . The ... computed tomography (CT) angiography and nuclear scans, is increasing ...
Cached Medicine News:Health News:Late nights can lead to higher risk of strokes and heart attacks 2Health News:Researchers develop outline that may help weigh benefits of new imaging technologies 2Health News:Schizophrenia Drugs May Spur Subtle Brain Tissue Loss 2Health News:'He loves me, he loves me not...': Women are more attracted to men whose feelings are unclear 2Health News:As Economy Picks Up, So Do Number of Nips & Tucks 2Health News:Risk of cancer increases with exposure to low-dose radiation 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: